Xbiotech Inc (XBIT) Annual Balance Sheets

Annual · GAAP · USD millions
Access XBIT quarterly Balance Sheets →
From Xbiotech Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent125.55
Short-term Investments, Total0.00
Cash & Short-term Investments125.00
Interest Receivable, Current0.36
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.04
Total Current Assets126.95
Equipment/Property/Plant Net23.13
Other Assets, Noncurrent0.00
Total Assets150.08
Liabilities
Accounts Payable, Current AC1.54
Accrued Liabilities, Current AC6.32
Convertible Debt, Current LO0.00
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA0.08
Total Current Liabilities7.93
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC11.80
Other liabilities, Noncurrent0.00
Total Liabilities9.73
Stockholders' Equity
Common Stock Value276.73
Retained Earnings / Accumulated Deficit-136.38
Other Equity0.00
Common Stockholder's Equity140.35
Total Stockholder's Equity140.35
Liabilities & Stockholder's Equity150.08
4 historic quarters locked

Sign in to unlock the full Xbiotech Inc balance sheet history.

About Xbiotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-26-001561

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License